期刊
FERTILITY AND STERILITY
卷 100, 期 6, 页码 1542-1546出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2013.07.2000
关键词
Azoospermia; 5 alpha-reductase; fertility; finasteride; oligospermia; semen; spermatogenesis
Objective: To determine the degree of improvement in semen parameters after finasteride discontinuation. Design: A prospective database of men presenting for a fertility evaluation was analyzed for semen and hormone parameters before and after discontinuation of finasteride. Setting: A male infertility specialty clinic. Patient(s): Men presenting for fertility evaluation from 2008-2012 on finasteride. Intervention(s): None. Main Outcome Measure(s): Semen and hormone parameters before and after discontinuation of finasteride. Result(s): At presentation, 27 (0.6%) of 4,400 men on finasteride. The mean duration of treatment with finasteride was 57.4 months, and mean dose was 1.04 mg/day. There was an average 11.6-fold increase in sperm counts after finasteride discontinuation. Of the men with severe oligospermia (<5 M/mL), 57% had counts increase to >15 M/mL after finasteride cessation. No man had a decrease in sperm count. There was no change in hormone parameters, sperm motility, or sperm morphology. Conclusion(s): Finasteride, even at low doses, may cause reduced sperm counts in some men. In this population, counts improved dramatically for the majority of men after finasteride discontinuation. The hormone parameters, sperm motility, and sperm morphology were unchanged after cessation. Finasteride should be discontinued in subfertile men with oligospermia, and used with caution in men who desire fertility. (C) 2013 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据